Try a new search

Format these results:

Searched for:

in-biosketch:true

person:schifp01

Total Results:

171


Is there a role for adjuvant treatment in patients with T3N0M0 breast cancer treated by modified radical mastectomy? [Meeting Abstract]

Hayes, MK; Ravi, A; Antonacci, R; Schiff, PB
ISI:A1997YD97100335
ISSN: 0033-8419
CID: 100769

Prognostic utility of extensive pathologic evaluation of biopsies in patients with clinically localized prostate cancer treated with definitive radiotherapy [Meeting Abstract]

Schiff, PB; Ennis, RD; Malyszko, BK; Rubin, MA
ISI:A1997XW28000382
ISSN: 0360-3016
CID: 100770

Predictions of positive bone scan or CT scan in asymptomatic patients with a rising PSA after definitive external beam therapy for prostate cancer [Meeting Abstract]

Woodhouse, SA; Schiff, PB; Malyszko, B; Ennis, RD
ISI:A1997YD97100127
ISSN: 0033-8419
CID: 100771

Figure-of-merit driven treatment plan optimization [Meeting Abstract]

Zaider, M; Amols, HI; Kung, JH; Schiff, PB
ISI:A1997YD97101240
ISSN: 0033-8419
CID: 100772

ATM mutations and genomic sensitivity in cancer patients with adverse late reactions to radiation therapy [Meeting Abstract]

Sawant, S.; Hall, E.; Schiff, P.; Mellado, W.; Smilenov, L.; Lieberman, H.; Brenner, D.; Pandita, T.
BIOSIS:PREV199799530507
ISSN: 0197-016x
CID: 100802

Benign and malignant mesothelioma

Chapter by: Antman KH; Pass HI; Schiff PB
in: Cancer : principles & practice of oncology by Devita VT; Hellman S; Rosenber SA [Eds]
Philadelphia PA : Lippincott-Raven, 1997
pp. 1853-1878
ISBN: 0397584245
CID: 5086

Figure-of-merit driven treatment plan optimization

Zaider M; Amols HI; Kung JH; Schiff PB
ORIGINAL:0006600
ISSN: 0140-0118
CID: 101085

Induction of an P53-independent apoptosis pathway and inhibition of P34CDC2 histone H1 kinase activity by Ro31-8220 in glioblastoma cells

Begemann, Martin; Kashimawo, Sharafadeen A.; Lunn, Ruth M.; Delohery, Thomas; Choi, Yu-Jeong A.; Kim, Susan; Heitjan, Daniel F.; Santella, Regina M.; Schiff, Peter B.; Bruce, Jeffrey N.; Weinstein, I. Bernard
BIOSIS:PREV199800019528
ISSN: 1059-1524
CID: 101080

Tubular carcinoma: Analysis of 1623 patients from the seer database

Rescigno, J.; Schiff, P. B.
BIOSIS:PREV199800069674
ISSN: 0167-6806
CID: 101083

Dosimetric considerations for catheter-based beta and gamma emitters in the therapy of neointimal hyperplasia in human coronary arteries

Amols, H I; Zaider, M; Weinberger, J; Ennis, R; Schiff, P B; Reinstein, L E
PURPOSE: Recent data indicate that intraluminal irradiation of coronary arteries following balloon angioplasty reduces proliferation of smooth muscle cells, neointima formation, and restenosis. We present calculations for various isotopes and geometries in an attempt to identify suitable source designs for such treatments. METHODS AND MATERIALS: Analytical calculations of dose distributions and dose rates are presented for 192Ir, 125I, 103Pd, 32P, and 90Sr for use in intracoronary irradiation. The effects of source geometry and positioning accuracy are studied. RESULTS: Accurate source centering, high dose rate, well-defined treatment volume, and radiation safety are all of concern; 15-20 Gy are required to a length of 2-3 cm of vessel wall (2-4 mm diameter). Dose must be confined to the region of the angioplasty, with reduced doses to normal tissues. Beta emitters have radiation safety advantages, but may not have suitable ranges for treating large diameter vessels. Gamma emitters deliver larger doses to normal tissues and to staff. Low energy x-ray emitters such as 125I and 103Pd reduce these risks but are not available at high enough activities. The feasibility of injecting a radioactive liquid directly into the angioplasty balloon is also explored. CONCLUSIONS: Accurate source centering is found to be of great importance. If this can be accomplished, then high energy beta emitters such as 90Sr would be ideal sources. Otherwise, gamma emitters such as 192Ir may be optimal. A liquid beta source would have optimal geometry and dose distribution, but available sources, such as 32P are unsafe for use with available balloon catheters
PMID: 8960521
ISSN: 0360-3016
CID: 100737